<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
 <id>https://coldtell.com/</id><title>Coldtell forecasts</title>
 <link href="https://coldtell.com/feed.xml" rel="self"/>
 <link href="https://coldtell.com/"/><updated>2026-08-01T00:00:00Z</updated>
 <entry><title>The transformer wall</title><id>https://coldtell.com/bets/transformer/</id><link href="https://coldtell.com/bets/transformer/"/><updated>2026-07-31T00:00:00Z</updated><category term="Technology / AI"/><summary>AI data centres are being held up not by chips, and not by making electricity, but by the unglamorous kit that moves power around: transformers, switchgear and grid connections.</summary></entry>
 <entry><title>Japan’s 30-year yield breaks 4.5%</title><id>https://coldtell.com/bets/jgb/</id><link href="https://coldtell.com/bets/jgb/"/><updated>2026-07-31T00:00:00Z</updated><category term="Money / markets"/><summary>Japan carries a large public-debt burden after decades of very low borrowing costs. This asks whether the 30-year government-bond yield closes above 4.5% by 2030.</summary></entry>
 <entry><title>China’s satellite fleet falls short</title><id>https://coldtell.com/bets/qianfan/</id><link href="https://coldtell.com/bets/qianfan/"/><updated>2026-08-01T00:00:00Z</updated><category term="Energy"/><summary>China is building a rival to Starlink. This bets it misses its own published deployment schedule.</summary></entry>
 <entry><title>Liver scarring becomes treatable</title><id>https://coldtell.com/bets/liver/</id><link href="https://coldtell.com/bets/liver/"/><updated>2026-07-28T00:00:00Z</updated><category term="Medicine"/><summary>Advanced scarring from fatty-liver disease has no approved treatment today. Three drugs are in late-stage trials to change that.</summary></entry>
 <entry><title>China out-builds US power three to one</title><id>https://coldtell.com/bets/power31/</id><link href="https://coldtell.com/bets/power31/"/><updated>2026-07-31T00:00:00Z</updated><category term="Energy"/><summary>China’s reported net additions of generation nameplate capacity stay at least three times the boundary-matched US total, every single year.</summary></entry>
 <entry><title>CoreWeave credit enters distress</title><id>https://coldtell.com/bets/gpu/</id><link href="https://coldtell.com/bets/gpu/"/><updated>2026-07-31T00:00:00Z</updated><category term="Money / markets"/><summary>CoreWeave is financing long-lived AI infrastructure while its computing assets can become obsolete quickly. This tracks a public default, distressed restructuring or rating fall to B-minus or lower.</summary></entry>
 <entry><title>Washington misses its encryption deadline</title><id>https://coldtell.com/bets/pqc/</id><link href="https://coldtell.com/bets/pqc/"/><updated>2026-07-31T00:00:00Z</updated><category term="Technology / AI"/><summary>High-value and high-impact federal systems have a 2030 migration target. This asks whether a later public assessment finds a majority miss, driven mainly by incomplete inventories or legacy cryptography.</summary></entry>
 <entry><title>Switching genes off without cutting them</title><id>https://coldtell.com/bets/silence/</id><link href="https://coldtell.com/bets/silence/"/><updated>2026-07-31T00:00:00Z</updated><category term="Medicine"/><summary>Normal gene editing cuts DNA. This switches a gene off and leaves it intact. Hepatitis B is simply the first disease it is being tried on.</summary></entry>
 <entry><title>The cholesterol nobody treats</title><id>https://coldtell.com/bets/lpa/</id><link href="https://coldtell.com/bets/lpa/"/><updated>2026-07-28T00:00:00Z</updated><category term="Medicine"/><summary>An inherited cholesterol-like particle raises heart-attack risk and has no treatment. Several drugs now lower it; the question is whether that prevents heart attacks.</summary></entry>
 <entry><title>Can AI invent, or only speed things up?</title><id>https://coldtell.com/bets/aiinvent/</id><link href="https://coldtell.com/bets/aiinvent/"/><updated>2026-07-31T00:00:00Z</updated><category term="Technology / AI"/><summary>AI has sped up drug chemistry for years. This asks the harder question: did AI come up with a biological idea nobody had?</summary></entry>
 <entry><title>Small reactors arrive too late</title><id>https://coldtell.com/bets/smr/</id><link href="https://coldtell.com/bets/smr/"/><updated>2026-07-31T00:00:00Z</updated><category term="Technology / AI"/><summary>Tech companies keep announcing nuclear deals for their data centres. This bets almost none of it is switched on this decade.</summary></entry>
 <entry><title>Sodium batteries scale anyway</title><id>https://coldtell.com/bets/sodium/</id><link href="https://coldtell.com/bets/sodium/"/><updated>2026-07-31T00:00:00Z</updated><category term="Energy"/><summary>Sodium-ion batteries trade cheaper, abundant inputs for lower energy density. This asks whether China still deploys them at grid scale while lithium is cheap.</summary></entry>
 <entry><title>Gas cannot be the bridge</title><id>https://coldtell.com/bets/gas/</id><link href="https://coldtell.com/bets/gas/"/><updated>2026-07-31T00:00:00Z</updated><category term="Energy"/><summary>New gas plants are widely proposed for AI demand, but prime turbine slots are heavily reserved into 2031.</summary></entry>
 <entry><title>A new antibiotic class reaches patients</title><id>https://coldtell.com/bets/abx/</id><link href="https://coldtell.com/bets/abx/"/><updated>2026-07-31T00:00:00Z</updated><category term="Medicine"/><summary>Zosurabalpin attacks drug-resistant Acinetobacter through a new target. The test is whether that mechanism survives a pivotal trial.</summary></entry>
</feed>
